NACL Industries Ltd. engages in the production of pesticides and insecticides. The company is headquartered in Hyderabad, Telangana and currently employs 1,353 full-time employees. The company went IPO on 2017-04-07. The firm is in the business of crop protection and manufactures both technical (active ingredient) and formulations. The company manufactures products in categories, such as pesticides, insecticides, acaricides, herbicides, fungicides and other plant growth chemicals. The company manufactures a range of technical, such as myclobutanil, propiconazole, profenofos, pretilachlor and tricyclazole. Its formulation business is mainly in the Indian market and sells through its retail dealer network across India. The company has a range of branded formulations. The company also exports technical and formulations and does toll manufacture for various companies. The company exports its products to over 30 nations across four continents. The firm's wholly owned subsidiaries include LR Research Laboratories Private Limited, Nagarjuna Agrichem (Australia) Pty Limited, NACL Spec-Chem Limited and NACL Multi-Chem Private Limited.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.